UPDATED Apr 20, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
XTNT | US$0.83 | -0.9% | 29.7% | US$108.1m | US$1.93 | PE163.8x | E33.4% | n/a | ||
SYK | US$325.43 | -4.9% | 7.2% | US$123.7b | US$365.69 | PE39.1x | E12.7% | 1.0% | ||
DGX | US$128.44 | -0.07% | -11.5% | US$14.3b | US$142.11 | PE16.8x | E8.2% | 2.3% | ||
ARAY | US$2.14 | -6.1% | -26.7% | US$212.2m | US$8.75 | PB4.5x | E108.5% | n/a | ||
NUTX | US$0.70 | 4.0% | -93.0% | US$34.7m | US$6.00 | PB0.6x | E90.3% | n/a | ||
USPH | US$99.09 | -3.5% | -5.9% | US$1.5b | US$119.30 | PE82.3x | E26.9% | 1.8% | ||
DRIO | US$1.16 | -5.7% | -67.3% | US$34.2m | US$5.67 | PS1.7x | E30.0% | n/a | ||
SSY | US$0.68 | -1.1% | -37.4% | US$4.8m | n/a | PB0.4x | n/a | n/a | ||
HCA | US$305.11 | -5.5% | 8.5% | US$80.7b | US$341.19 | PE15.4x | E6.4% | 0.9% |